Nancy J. Wysenski

2011

In 2011, Nancy J. Wysenski earned a total compensation of $3.4M as EVP & Chief Commercial Officer at Vertex Pharmaceuticals, a 117% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$454,230
Option Awards$1,914,319
Salary$503,004
Stock Awards$468,738
Other$12,477
Total$3,352,768

Wysenski received $1.9M in option awards, accounting for 57% of the total pay in 2011.

Wysenski also received $454.2K in non-equity incentive plan, $503K in salary, $468.7K in stock awards and $12.5K in other compensation.

Rankings

In 2011, Nancy J. Wysenski's compensation ranked 1,838th out of 10,747 executives tracked by ExecPay. In other words, Wysenski earned more than 82.9% of executives.

ClassificationRankingPercentile
All
1,838
out of 10,747
83rd
Division
Manufacturing
667
out of 3,958
83rd
Major group
Chemicals And Allied Products
142
out of 1,034
86th
Industry group
Drugs
79
out of 782
90th
Industry
Pharmaceutical Preparations
66
out of 567
88th
Source: SEC filing on April 10, 2012.

Wysenski's colleagues

We found four more compensation records of executives who worked with Nancy J. Wysenski at Vertex Pharmaceuticals in 2011.

2011

Matthew Emmens

Vertex Pharmaceuticals

Chief Executive Officer

2011

Jeffrey Leiden

Vertex Pharmaceuticals

Chief Executive Officer

2011

Peter Mueller

Vertex Pharmaceuticals

Chief Scientific Officer

2011

Ian Smith

Vertex Pharmaceuticals

Chief Financial Officer

In-depth

You may also like